Figure 2. Time-of-day influences body mass loss following doxorubicin/cyclophosphamide administration.

(a) Change in body mass after injection at ZT 2, and (b) ZT 14. (c) % change in body mass from time-matched vehicle treated mice at 24 h post-injection in animals injected at ZT 2 and ZT 14. ((N = 7–8/group/timepoint) Error bars represent SEM. *p < 0.05)).